πŸ‡ΊπŸ‡Έ FDA
Patent

US 8975231

Bone morphogenic protein binding peptide

granted A61KA61K35/28A61K38/12

Quick answer

US patent 8975231 (Bone morphogenic protein binding peptide) held by THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Grant date
Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K35/28, A61K38/12, A61K38/1841, A61K38/1875